Hemostasis Clinical Trials

7 recruiting

Hemostasis Trials at a Glance

12 actively recruiting trials for hemostasis are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Aswān, Beijing, and Beijing. Lead sponsors running hemostasis studies include Centre Hospitalier Universitaire Dijon, Centre Hospitalier Universitaire, Amiens, and Aswan University.

Browse hemostasis trials by phase

About Hemostasis Clinical Trials

Looking for clinical trials for Hemostasis? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hemostasis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hemostasis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

A Study of ETHIZIA Versus SURGICEL Original in Controlling Soft Tissue Bleeding During Open Surgery

HemostasisHemostatic Techniques
Ethicon, Inc.108 enrolled8 locationsNCT06664788
Recruiting
Not Applicable

Comparison of Efficacy and Safety of Manual Syringing Versus Pneumatic Pressure Bag for Blood Transfusion in Patients Undergoing Cesarean Section With Major Obstetric Hemorrhage

Obstetric HemostasisIntravascular HemolysisMajor Obstetric Hemorrhage+2 more
Aswan University50 enrolled1 locationNCT07466719
Recruiting

Preliminary Exploration of Factors Affecting Complete Hemostasis and Supine Time After Removal of Femoral Arterial Sheath in ICU Patients

Coronary Artery DiseasePercutaneous Coronary InterventionTranscatheter Aortic Valve Implantation (TAVI)+2 more
National Taiwan University Hospital157 enrolled1 locationNCT07469397
Recruiting

Normal Hemostasis Values in Premature Infants

Premature Infant, Hemostasis
University Hospital, Strasbourg, France1,000 enrolled1 locationNCT07349251
Recruiting

Investigation of the Genetics of Hematologic Diseases

Diamond-Blackfan AnemiaDyskeratosis CongenitaFanconi Anemia+10 more
St. Jude Children's Research Hospital1,716 enrolled1 locationNCT02720679
Recruiting

Choice of Anticoagulant for Primary Hemostasis Studies With PFA200® (Platelet Function Analyser)

Hemostasis
Centre Hospitalier Universitaire Dijon100 enrolled1 locationNCT06753838
Recruiting

Thrombo Embolic Events in Hospitalized Patients With Covid-19 Serious Acute Pneumopathy

CoagulationCOVID-19Hemostasis
Centre Hospitalier Universitaire, Amiens100 enrolled1 locationNCT04377490
Recruiting
Not Applicable

EFFECTİVİTY OF CHITOSAN COVERED GAUZE IN POSTPARTUM HEMORRHAGIC OBSTETRIC LACERATIONS

Effectiveness of Chitosan Covered Gauze to Stop Bleeding in Post-partum TearsComparison of the Effect of Chitosan Covered Gauze With Suturing in Terms of Hemostasis in Post-partum Haemorrhagic Tears
Istanbul Training and Research Hospital62 enrolled1 locationNCT06998641
Recruiting
Not Applicable

Efficacy of ARISTA-AH for Restoring Hemostasis Following Posterior Long-segment Spinal Fusion.

HemostasisSpinal FusionHemostatics+1 more
Polyclinique Bordeaux Nord Aquitaine100 enrolled1 locationNCT05323448
Recruiting
Not Applicable

Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study

Atrial FibrillationHemostasis
Kansas City Heart Rhythm Research Foundation110 enrolled6 locationsNCT06078735
Recruiting
Not Applicable

Effect of Patent Hemostatic Device (PHD) With Quantitative Pressure on Radial Artery Hemostasis After CAG/PCI

Percutaneous Coronary InterventionHemostasis
Peking University First Hospital200 enrolled2 locationsNCT05790603
Recruiting

Hemostasis in Liver Cirrhosis and Hepatocellular Cancer

Hemostasis in Decompensated Liver CirrhosisInflammation in Decompensated Liver Cirrhosis
Region Stockholm100 enrolled1 locationNCT06212635